Author:
Budhwani Henna,Yigit Ibrahim,Stocks Jacob B.,Stoner Marie C.D.,Browne Erica,Pettifor Audrey E.,Hightow-Weidman Lisa B.
Funder
National Institute on Minority Health and Health Disparities
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. US Centers for Disease Control and Prevention About Mpox. 2023; https://www.cdc.gov/poxvirus/mpox/about/. Accessed February 5, 2024.
2. US Centers for Disease Control and Prevention Mpox. 2022–2023 outbreak cases and data. https://www.cdc.gov/poxvirus/mpox/response/2022/us-map.html. Accessed January 18, 2024.
3. Bertran M, Andrews N, Davison C, et al. Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. The Lancet Infectious Diseases; 2023.
4. Wolff Sagy Y, Zucker R, Hammerman A, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023;29(3):748–52.
5. Payne AB, Ray LC, Cole MM, et al. Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons—43 US jurisdictions, July 31–October 1, 2022. Morb Mortal Wkly Rep. 2022;71(49):1560.